Humacyte Stock Price on May 3, 2024

HUMA Stock  USD 4.43  0.18  4.24%   
If you're considering investing in Humacyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of Humacyte stands at 4.43, as last reported on the 5th of December, with the highest price reaching 4.44 and the lowest price hitting 4.25 during the day. Humacyte holds Efficiency (Sharpe) Ratio of -0.0299, which attests that the entity had a -0.0299% return per unit of risk over the last 3 months. Humacyte exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Humacyte's Risk Adjusted Performance of (0.02), standard deviation of 4.94, and Market Risk Adjusted Performance of (0.13) to validate the risk estimate we provide.
  
At present, Humacyte's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 7.1 M, whereas Total Stockholder Equity is forecasted to decline to about 7.6 M. . At present, Humacyte's Price Book Value Ratio is projected to increase based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 96.95. Humacyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0299

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsHUMA

Estimated Market Risk

 4.96
  actual daily
44
56% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Humacyte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Humacyte by adding Humacyte to a well-diversified portfolio.
Price Book
30.2811
Enterprise Value Ebitda
4.3389
Price Sales
153.9075
Shares Float
91.3 M
Wall Street Target Price
13

Humacyte Main Headline on 3rd of May 2024

Filed transaction by Humacyte Officer Chief Commercial Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Humacyte Valuation on May 3, 2024

It is possible to determine the worth of Humacyte on a given historical date. On May 3, 2024 Humacyte was worth 4.5 at the beginning of the trading date compared to the closed value of 4.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Humacyte stock. Still, in general, we apply an absolute valuation method to find Humacyte's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Humacyte where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Humacyte's related companies.
 Open High Low Close Volume
  4.50    4.55    4.28    4.40    976,675  
05/03/2024
  4.50    4.57    4.36    4.41    803,493  
  4.50    4.55    4.31    4.54    1,017,934  
Backtest Humacyte  |  Humacyte History  |  Humacyte Valuation   PreviousNext  
Open Value
4.5
4.41
Closing Value
19.39
Upside

Humacyte Trading Date Momentum on May 3, 2024

On May 06 2024 Humacyte was traded for  4.54  at the closing time. The top price for the day was 4.55  and the lowest listed price was  4.31 . The trading volume for the day was 1 M. The trading history from May 6, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 2.95% . The trading delta at closing time against the current closing price is 7.48% .

Humacyte Fundamentals Correlations and Trends

By evaluating Humacyte's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Humacyte's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Humacyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Humacyte Stock history

Humacyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Humacyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Humacyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Humacyte stock prices may prove useful in developing a viable investing in Humacyte
Last ReportedProjected for Next Year
Common Stock Shares Outstanding103.4 M61.4 M
Net Loss-13.8 M-14.4 M

Humacyte Quarterly Net Working Capital

78.35 Million

Humacyte Stock Technical Analysis

Humacyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Humacyte technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Humacyte trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Humacyte Period Price Range

Low
December 5, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Humacyte cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Humacyte December 5, 2024 Market Strength

Market strength indicators help investors to evaluate how Humacyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Humacyte shares will generate the highest return on investment. By undertsting and applying Humacyte stock market strength indicators, traders can identify Humacyte entry and exit signals to maximize returns

Humacyte Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Humacyte's price direction in advance. Along with the technical and fundamental analysis of Humacyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Humacyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Humacyte Stock analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals